How come there is no suggestion of changing management? Does Kempler or the Board have unchallangeable control? One of the basic investment risks is a company where the same person acts as Chair and MD - which is what happens here. How come none of the major shareholders are challenging the current state of play?
PBT- Management/FDA, page-4
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.60M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $467.9K | 116.7M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 67 | 115823759 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 83066833 | 4 |
View Market Depth
| Last trade - 13.05pm 31/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |